Two Developers Say Experimental Drugs Are Safe for Humans. Two experimental drugs designed to treat anthrax infection have shown promise in recent tests, according to their developers — evidence that the nation might eventually produce new defenses against a weapon that terrorized Capitol Hill and much of the East Coast in late 2001. Human Genome Sciences Inc., a Rockville biotechnology company, plans to reveal today that its anti-anthrax drug appears safe for human use based on a recent test. The company disclosed yesterday at a scientific meeting in Baltimore that separate tests in rabbits suggested the drug might be effective if given within 12 hours of exposure to anthrax. A second company, Elusys Therapeutics Inc. of Pine Brook, N.J., said a similar anti-anthrax drug it is developing was able, if administered immediately ahead of time, to protect rabbits and mice from the lethal effects of inhaling anthrax spores. Full Story
About OODA Analyst
OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.